Stay updated with breaking news from Sciences Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Thompson Investment Management Inc. lessened its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 196,693 shares of the medical research company’s stock after selling 2,285 shares during the […]
Quantum Private Wealth LLC trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 58,163 shares of the medical research company’s stock after selling 1,413 shares during the quarter. Exact Sciences […]
United Capital Financial Advisers LLC bought a new stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 8,149 shares of the medical research company’s stock, valued at approximately $265,000. A […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has been given an average recommendation of “Moderate Buy” by the fifteen research firms that are covering the stock, MarketBeat reports. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating on the company. The average 1-year price objective […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) has earned an average recommendation of “Moderate Buy” from the fifteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 12-month price target […]